Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.
about
Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapseDown-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin.The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function.SSTR5 P335L monoclonal antibody differentiates pancreatic neuroendocrine neuroplasms with different SSTR5 genotypes.Negative regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5.Peptide receptor targeting in cancer: the somatostatin paradigm.Relationship between expression of gastrin, somatostatin, Fas/FasL and caspases in large intestinal carcinoma.Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation.Upregulated Expression of SSTR3 is Involved in Neuronal Apoptosis After Intracerebral Hemorrhage in Adult Rats.Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in colorectal cancer.Value of SSTR2A and Claudin - 1 in Differentiating Meningioma from Schwannoma and Hemangiopericytoma.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New NomenclaturePET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors
P2860
Q28540624-DCB85349-D607-4174-A541-2E6EE2F29822Q33801805-D99538F9-70F2-483C-97FA-444D97DAB078Q34065842-50F821B9-706D-4B68-88D9-57A08919D718Q35601022-DE490F56-981A-4C33-A8B0-81789E56CE33Q36065515-E4C317F3-08E2-4D11-877E-C69192F16165Q36638046-D6C09331-92BA-443C-8566-4FC52B39E081Q37261898-988B67EE-B288-472C-B84B-669AB054FF83Q37898112-7AA739CD-9628-4508-B240-FB198A0E9A25Q42438003-5FD09D02-097B-40F3-A884-47131FD367DAQ47995985-BD50E234-7660-4204-B79C-B89E0328AA83Q53670860-84359B80-1831-4E18-B107-62E22175103BQ53838103-C9B51477-9B77-4BA0-BA15-0B54BB8A5030Q57144951-595D5005-F789-4193-A28D-957F31833F48Q59074896-0FBA0220-5F4D-4957-9DB3-B3786D6257E8
P2860
Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Relationship between somatosta ...... and p53 in colorectal cancer.
@ast
Relationship between somatosta ...... and p53 in colorectal cancer.
@en
type
label
Relationship between somatosta ...... and p53 in colorectal cancer.
@ast
Relationship between somatosta ...... and p53 in colorectal cancer.
@en
prefLabel
Relationship between somatosta ...... and p53 in colorectal cancer.
@ast
Relationship between somatosta ...... and p53 in colorectal cancer.
@en
P2093
P2860
P356
P1476
Relationship between somatosta ...... and p53 in colorectal cancer.
@en
P2093
Cheng-Zhi Qiu
Chuan Wang
Jian-Long Qiu
Shi-Ze Zhu
Zhong-Xin Huang
P2860
P304
P356
10.3748/WJG.V12.I13.2011
P407
P577
2006-04-01T00:00:00Z